Effect of Ritonavir-Containing Regimens on Lipids Compared to Other Protease Inhibitors

Author： Segarra-Newnham Marisel   Haselkorn Susan M.  

Publisher： Haworth Press

ISSN： 1068-7777

Source： Journal of Infectious Disease Pharmacotherapy, Vol.6, Iss.3, 2004-01, pp. : 37-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal Insufficiency Has No Effect on the Pharmacokinetics of Vicriviroc in a Ritonavir-Containing Regimen

By Kasserra Claudia  

Clinical Pharmacokinetics, Vol. 49, Iss. 6, 2010-06 ,pp. : 397-406

Adis International

Access to resources Recommend Favorite

Vinyl Sulfone Containing Parasitic Cysteinyl Protease Inhibitors

By  

Current Bioactive Compounds, Vol. 7, Iss. 4, 2011-12 ,pp. : 218-236

Bentham Science Publishers

Access to resources Recommend Favorite

Cysteine Protease Inhibitors Containing Small Rings

By  

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 6, 2003-09 ,pp. : 585-596

Bentham Science Publishers

Access to resources Recommend Favorite

Tenofovir disoproxil fumarate (TDF) plus ritonavir-boosted protease inhibitor (PI) regimens appear to be associated with greater renal function decline

By  

Reactions Weekly, Vol. 1, Iss. 1188, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Tenofovir disoproxil fumarate (TDF) plus ritonavir-boosted protease inhibitor (PI) regimens appear to be associated with greater renal function decline

By  

Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite